Sienna Biopharmaceuticals takes in additional Series A funds

Westlake Village, California-based Sienna Biopharmaceuticals, which is focused on medical dermatology and aesthetics, has raised an additional $12 million in its Series A funding, bringing the total tally to about $46 million. The investors in this round included ARCH Venture Partners, Partner Fund Management and Two River.

Source: Press Release